Research ArticleExperimental Studies
PRPF4 Knockdown Suppresses Glioblastoma Progression via the p38 MAPK and ERK Signaling Pathways
WANSOO KIM, SONG PARK, SE-HYEON HAN, HEE-YEON KIM, SEOUNG-WOO LEE, DAEHWAN KIM, SOYOUNG JANG, JIN-KYU PARK, JEE EUN HAN, CHOONOK KIM, JAELIM CHO, ETHAN SEAH, JIYEON LEE, ZAE YOUNG RYOO and SEONG-KYOON CHOI
Anticancer Research February 2025, 45 (2) 549-564; DOI: https://doi.org/10.21873/anticanres.17443
WANSOO KIM
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea
2SilicoPharm Inc., Daegu, Republic of Korea
SONG PARK
3Division of Animal Science, Gyeongsang National University, Jinju, Republic of Korea
4Institute of Agriculture and Life Science (IALS), Gyeongsang National University, Jinju, Republic of Korea
5Institute of Smart Farm Research Center, Gyeongsang National University, Jinju, Republic of Korea
SE-HYEON HAN
6Department of Companion Animal Industry, College of Health Science, Honam University, Gwangju, Republic of Korea
HEE-YEON KIM
7Core Protein Resources Center, DGIST, Daegu, Republic of Korea
SEOUNG-WOO LEE
7Core Protein Resources Center, DGIST, Daegu, Republic of Korea
8Division of Biomedical Technology, DGIST, Daegu, Republic of Korea
DAEHWAN KIM
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea
SOYOUNG JANG
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea
JIN-KYU PARK
9College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea
JEE EUN HAN
9College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea
CHOONOK KIM
10J INTS BIO Inc., Seoul, Republic of Korea
JAELIM CHO
10J INTS BIO Inc., Seoul, Republic of Korea
ETHAN SEAH
10J INTS BIO Inc., Seoul, Republic of Korea
JIYEON LEE
10J INTS BIO Inc., Seoul, Republic of Korea
ZAE YOUNG RYOO
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea
SEONG-KYOON CHOI
7Core Protein Resources Center, DGIST, Daegu, Republic of Korea
8Division of Biomedical Technology, DGIST, Daegu, Republic of Korea

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
PRPF4 Knockdown Suppresses Glioblastoma Progression via the p38 MAPK and ERK Signaling Pathways
WANSOO KIM, SONG PARK, SE-HYEON HAN, HEE-YEON KIM, SEOUNG-WOO LEE, DAEHWAN KIM, SOYOUNG JANG, JIN-KYU PARK, JEE EUN HAN, CHOONOK KIM, JAELIM CHO, ETHAN SEAH, JIYEON LEE, ZAE YOUNG RYOO, SEONG-KYOON CHOI
Anticancer Research Feb 2025, 45 (2) 549-564; DOI: 10.21873/anticanres.17443
PRPF4 Knockdown Suppresses Glioblastoma Progression via the p38 MAPK and ERK Signaling Pathways
WANSOO KIM, SONG PARK, SE-HYEON HAN, HEE-YEON KIM, SEOUNG-WOO LEE, DAEHWAN KIM, SOYOUNG JANG, JIN-KYU PARK, JEE EUN HAN, CHOONOK KIM, JAELIM CHO, ETHAN SEAH, JIYEON LEE, ZAE YOUNG RYOO, SEONG-KYOON CHOI
Anticancer Research Feb 2025, 45 (2) 549-564; DOI: 10.21873/anticanres.17443





